Patents by Inventor Larry M. Rose

Larry M. Rose has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6783936
    Abstract: This invention provides novel peptide epitopes recognized by the non-Hodgkin's B cell lymphoma reactive Lym-1 antibody. These novel peptide epitopes are capable of generating antibodies directed against Lym-1 peptide epitope expressing B-NHL cells. This invention is also directed to the treatment of B-NHL.
    Type: Grant
    Filed: April 10, 2001
    Date of Patent: August 31, 2004
    Assignee: The Regents of the University of California
    Inventors: Larry M. Rose, Claude F. Meares, Robert T. O'Donnell
  • Publication number: 20010019828
    Abstract: This invention provides novel peptide epitopes recognized by the non-Hodgkin's B cell lymphoma reactive Lym-1 antibody. These novel peptide epitopes are capable of generating antibodies directed against Lym-1 peptide epitope expressing B-NHL cells. This invention is also directed to the treatment of B-NHL.
    Type: Application
    Filed: April 10, 2001
    Publication date: September 6, 2001
    Inventors: Larry M. Rose, Claude F. Meares, Robert T. O'Donnell
  • Patent number: 6217871
    Abstract: This invention provides novel peptide epitopes recognized by the non-Hodgkin's B cell lymphoma reactive Lym-1 antibody. These novel peptide epitopes are capable of generating antibodies directed against Lym-1 peptide epitope expressing B-NHL cells. This invention is also directed to the treatment of B-NHL.
    Type: Grant
    Filed: October 28, 1998
    Date of Patent: April 17, 2001
    Assignee: The Regents of the University of California
    Inventors: Larry M. Rose, Claude F. Meares, Robert T. O'Donnell